|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.449 SEK | +0.45% |
|
-0.22% | -14.15% |
| Apr. 16 | Mendus AB Announces Board Changes | CI |
| Mar. 27 | Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML | CI |
On June 23, 2022, Immunicum AB (publ) changed its name to Mendus AB.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.15% | 42.14M | |
| +33.37% | 49.46B | |
| +1.55% | 42.58B | |
| +49.11% | 42.49B | |
| -4.22% | 29.09B | |
| +11.57% | 26.61B | |
| -21.00% | 18.64B | |
| +7.36% | 13.16B | |
| +28.30% | 12.55B | |
| +23.80% | 12.1B |
MENDUS AB 
